Petronella O Witteveen

3PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 24, 2026
Clinical Decision-Making Regarding the Added Value of Postoperative Chemotherapy After Complete Secondary Cytoreductive Surgery in Unifocal First Recurrent Epithelial Ovarian Cancer-An International Expert Survey.

|Jun 13, 2025
The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.

Geertruid J Brink, Nizar Hami, Hans W Nijman

|Nov 27, 2024
Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.

Geertruid J Brink, Nizar Hami, Sander Mertens

Pageof 1

Frequent Collaborators

3 joint publications

Ronald P Zweemer

2 joint publications

Geertruid J Brink

2 joint publications

Hans W Nijman

2 joint publications

Luc R C W van Lonkhuijzen

2 joint publications

Christine A R Lok

2 joint publications

Cornelis D de Kroon

2 joint publications

Jurgen M J Piek

2 joint publications

Jolijn W Groeneweg

1 joint publications

Nizar Hami

1 joint publications

Sander Mertens

Frequent Collaborators

3 joint publications

Ronald P Zweemer

2 joint publications

Geertruid J Brink

2 joint publications

Hans W Nijman

2 joint publications

Luc R C W van Lonkhuijzen

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us